- Ownership
-
Cortexyme, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, April 23rd, 2025 | 2024 | Charles Ryan President | 500,000 | 0 | 0 | 177,500 | 25,600 | 893,050 |
| Wednesday, April 23rd, 2025 | 2023 | Brendan Hannah Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | 425,000 | 0 | 0 | 178,500 | 4,000 | 847,500 |
| Wednesday, April 23rd, 2025 | 2023 | Brendan Hannah Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | 425,000 | 0 | 0 | 178,500 | 4,000 | 847,500 |
| Wednesday, April 23rd, 2025 | 2024 | Brendan Hannah Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | 425,000 | 0 | 0 | 150,875 | 4,000 | 1,365,875 |
| Wednesday, April 23rd, 2025 | 2024 | Brendan Hannah Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | 425,000 | 0 | 0 | 150,875 | 4,000 | 1,365,875 |
| Wednesday, April 23rd, 2025 | 2023 | Charles Ryan President | 147,756 | 0 | 0 | 70,000 | 11,200 | 817,556 |
| Wednesday, April 23rd, 2025 | 2023 | Charles Ryan President | 147,756 | 0 | 0 | 70,000 | 11,200 | 817,556 |
| Wednesday, April 23rd, 2025 | 2024 | Charles Ryan President | 500,000 | 0 | 0 | 177,500 | 25,600 | 893,050 |
| Wednesday, April 23rd, 2025 | 2024 | Dirk Thye Chief Executive Officer and Chief Medical Officer | 550,000 | 0 | 0 | 213,125 | 4,000 | 2,732,125 |
| Wednesday, April 23rd, 2025 | 2024 | Dirk Thye Chief Executive Officer and Chief Medical Officer | 550,000 | 0 | 0 | 213,125 | 4,000 | 2,732,125 |
| Wednesday, April 23rd, 2025 | 2023 | Dirk Thye Chief Executive Officer and Chief Medical Officer | 550,000 | 0 | 0 | 302,500 | 4,000 | 1,330,500 |
| Wednesday, April 23rd, 2025 | 2023 | Dirk Thye Chief Executive Officer and Chief Medical Officer | 550,000 | 0 | 0 | 302,500 | 4,000 | 1,330,500 |
| Wednesday, April 27th, 2022 | 2020 | Leslie Holsinger, Ph.D. Executive Vice President of Preclinical Development | 405,000 | 0 | 0 | 162,000 | 0 | 9,198,100 |
| Wednesday, April 27th, 2022 | 2020 | Caryn McDowell Chief Legal and Administrative Officer and Corporate Secretary | 268,077 | 0 | 0 | 111,048 | 0 | 10,172,875 |
| Wednesday, April 27th, 2022 | 2021 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 450,000 | 0 | 0 | 177,750 | 4,000 | 631,750 |
| Wednesday, April 27th, 2022 | 2021 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 450,000 | 0 | 0 | 177,750 | 4,000 | 631,750 |
| Wednesday, April 27th, 2022 | 2020 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 410,000 | 0 | 0 | 164,000 | 0 | 8,204,000 |
| Wednesday, April 27th, 2022 | 2020 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 410,000 | 0 | 0 | 164,000 | 0 | 8,204,000 |
| Wednesday, April 27th, 2022 | 2021 | Leslie Holsinger, Ph.D. Executive Vice President of Preclinical Development | 430,000 | 0 | 0 | 169,850 | 4,000 | 603,850 |
| Wednesday, April 27th, 2022 | 2021 | Leslie Holsinger, Ph.D. Executive Vice President of Preclinical Development | 430,000 | 0 | 0 | 169,850 | 4,000 | 603,850 |
| Wednesday, April 27th, 2022 | 2020 | Leslie Holsinger, Ph.D. Executive Vice President of Preclinical Development | 405,000 | 0 | 0 | 162,000 | 0 | 9,198,100 |
| Wednesday, April 27th, 2022 | 2021 | Casey C. Lynch Former President and Chief Executive Officer | 575,000 | 0 | 0 | 308,344 | 4,000 | 887,344 |
| Wednesday, April 27th, 2022 | 2021 | Casey C. Lynch Former President and Chief Executive Officer | 575,000 | 0 | 0 | 308,344 | 4,000 | 887,344 |
| Wednesday, April 27th, 2022 | 2020 | Casey C. Lynch Former President and Chief Executive Officer | 525,000 | 0 | 0 | 262,500 | 0 | 14,140,000 |
| Wednesday, April 27th, 2022 | 2020 | Casey C. Lynch Former President and Chief Executive Officer | 525,000 | 0 | 0 | 262,500 | 0 | 14,140,000 |
| Wednesday, April 27th, 2022 | 2021 | Christopher Lowe Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer | 445,000 | 0 | 0 | 196,652 | 4,000 | 2,123,652 |
| Wednesday, April 27th, 2022 | 2021 | Christopher Lowe Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer | 445,000 | 0 | 0 | 196,652 | 4,000 | 2,123,652 |
| Wednesday, April 27th, 2022 | 2020 | Christopher Lowe Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer | 390,000 | 0 | 0 | 156,000 | 0 | 9,177,100 |
| Wednesday, April 27th, 2022 | 2020 | Christopher Lowe Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer | 390,000 | 0 | 0 | 156,000 | 0 | 9,177,100 |
| Wednesday, April 27th, 2022 | 2019 | Christopher Lowe Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer | 357,308 | 0 | 0 | 104,625 | 0 | 461,933 |
| Wednesday, April 27th, 2022 | 2019 | Christopher Lowe Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer | 357,308 | 0 | 0 | 104,625 | 0 | 461,933 |
| Wednesday, April 27th, 2022 | 2019 | Leslie Holsinger, Ph.D. Executive Vice President of Preclinical Development | 353,646 | 0 | 0 | 89,250 | 0 | 442,896 |
| Wednesday, April 27th, 2022 | 2019 | Leslie Holsinger, Ph.D. Executive Vice President of Preclinical Development | 353,646 | 0 | 0 | 89,250 | 0 | 442,896 |
| Wednesday, April 27th, 2022 | 2019 | Casey C. Lynch Former President and Chief Executive Officer | 415,577 | 0 | 0 | 144,375 | 0 | 559,952 |
| Wednesday, April 27th, 2022 | 2019 | Casey C. Lynch Former President and Chief Executive Officer | 415,577 | 0 | 0 | 144,375 | 0 | 559,952 |
| Wednesday, April 27th, 2022 | 2019 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 373,077 | 0 | 0 | 106,625 | 0 | 1,100,168 |
| Wednesday, April 27th, 2022 | 2019 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 373,077 | 0 | 0 | 106,625 | 0 | 1,100,168 |
| Wednesday, April 27th, 2022 | 2021 | Caryn McDowell Chief Legal and Administrative Officer and Corporate Secretary | 430,000 | 0 | 0 | 169,850 | 4,000 | 603,850 |
| Wednesday, April 27th, 2022 | 2021 | Caryn McDowell Chief Legal and Administrative Officer and Corporate Secretary | 430,000 | 0 | 0 | 169,850 | 4,000 | 603,850 |
| Wednesday, April 27th, 2022 | 2020 | Caryn McDowell Chief Legal and Administrative Officer and Corporate Secretary | 268,077 | 0 | 0 | 111,048 | 0 | 10,172,875 |
| Wednesday, April 22nd, 2020 | 2019 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 373,077 | 0 | 620,466 | 106,625 | 0 | 1,100,168 |
| Wednesday, April 22nd, 2020 | 2019 | Michael Detke, M.D., Ph.D. Chief Medical Officer | 373,077 | 0 | 620,466 | 106,625 | 0 | 1,100,168 |
| Wednesday, April 22nd, 2020 | 2019 | Kristen Gafric | 328,462 | 0 | 1,541,475 | 83,000 | 0 | 1,952,937 |
| Wednesday, April 22nd, 2020 | 2019 | Kristen Gafric | 328,462 | 0 | 1,541,475 | 83,000 | 0 | 1,952,937 |
| Wednesday, April 22nd, 2020 | 2018 | Casey C. Lynch Chief Executive Officer | 277,019 | 82,500 | 557,814 | 0 | 0 | 917,333 |
| Wednesday, April 22nd, 2020 | 2018 | Casey C. Lynch Chief Executive Officer | 277,019 | 82,500 | 557,814 | 0 | 0 | 917,333 |
| Wednesday, April 22nd, 2020 | 2019 | Casey C. Lynch Chief Executive Officer | 415,577 | 0 | 0 | 144,375 | 0 | 559,952 |
| Wednesday, April 22nd, 2020 | 2019 | Casey C. Lynch Chief Executive Officer | 415,577 | 0 | 0 | 144,375 | 0 | 559,952 |
